Gardasil Approved for Anal Cancer Prevention


The FDA today approved Merck’s Gardasil HPV vaccine for prevention of anal cancer in both males and females ages 9 through 26 years.

HPV — human papillomavirus — is a sexually transmitted infection. It most commonly causes genital warts, but it also causes several cancers and precancerous lesions.

Gardasil already is approved for preventing cervical, vulvar, and vaginal cancer in females, and for preventing genital warts in both males and females.

However, the vaccine is routinely recommended only for girls. It remains optional for boys. Another HPV vaccine, Cervarix, is approved only for cancer prevention in girls.

Anal cancer is relatively rare in the U.S. — about 5,300 cases a year. However, cases have been steadily increasing.

Read the article.

Jason Rink is the Editor-in-Chief of The Liberty Voice. Executive Director of the Foundation for a Free Society. He is the producer and director of Nullification: The Rightful Remedy, and the author of “Ron Paul: Father of the Tea Party” the biography of Congressman Ron Paul. See more of his work at his writing at and his film production work at

Leave a Reply

Your email address will not be published.